<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="372">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05156307</url>
  </required_header>
  <id_info>
    <org_study_id>275691</org_study_id>
    <nct_id>NCT05156307</nct_id>
  </id_info>
  <brief_title>Accuracy and Predictive Values for Colorectal Cancer of Quantitative FIT in Symptomatic Patients in Primary Care</brief_title>
  <official_title>Accuracy and Predictive Values for Colorectal Cancer of a Quantitative Faecal Immunochemical Test in Symptomatic Patients in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Region Jämtland Härjedalen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Östergötland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uppsala County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dalarna County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Landstinget i Värmland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Örebro County</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine accuracy and predictive values for colorectal cancer of&#xD;
      a faecal quantitative immunochemical test (FIT) in unselected symptomatic patients presenting&#xD;
      in primary care. Main reference test will be linkage to a nationwide colorectal cancer&#xD;
      registry.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a nationwide multi-centre study in primary care, Sweden. Patients from the age of 40&#xD;
      years and above presenting in primary care with symptoms associated with colorectal cancer&#xD;
      prompting their GP to take actions are eligible.&#xD;
&#xD;
      Consenting patients will fill out a short form on symptoms during last 4 weeks. They will&#xD;
      provide 2 faecal samples from 2 different days. Samples will be analysed at any of three&#xD;
      laboratories within 5 days using QuikRead go® (Aidian Oy). The analytical working range is&#xD;
      10-200 µg Hb/g faeces. The outcome will be reported as the concentration of first test (FIT&#xD;
      1) and highest concentration of two tests (FIT max). The outcome of the study FIT will remain&#xD;
      within the study and GPs must request a separate FOBT for clinical purposes.&#xD;
&#xD;
      Reference test will be linkage to the Swedish Colorectal Cancer Registry (with in practice&#xD;
      complete coverage) after at most 2 years for all patients. Accuracy and predictive values&#xD;
      will be determined and ROC-curves analysed.&#xD;
&#xD;
      Some patients included in the study will be referred for colonoscopy for clinical reasons,&#xD;
      and the outcome of FIT in relation to colonoscopy findings will be reported for this group as&#xD;
      well.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Colorectal cancer</measure>
    <time_frame>2 years</time_frame>
    <description>Linkage to cancer registry</description>
  </primary_outcome>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Colorectal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged ≥ 40 years presenting in primary care with symptoms associated with&#xD;
        colorectal cancer prompting their GP to take actions are eligible. This involves referral&#xD;
        for any endoscopic or radiological examination of the large bowel, laboratory testing,&#xD;
        including faecal occult blood test according to local routines, or clinical follow-up&#xD;
        within soon. Both urgent referrals and patients planned for at least initial management in&#xD;
        primary care are eligible, ie there will be no attempt to delimitate the study population&#xD;
        based on any categorization of symptoms into &quot;alarm&quot; and &quot;non-alarm&quot; symptoms. The study&#xD;
        population will be defined by primary care physicians´ clinical reasoning and assessment of&#xD;
        colorectal cancer as a (more or less) possible diagnosis at the unique consultation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients presenting in primary care with symptoms associated with colorectal cancer&#xD;
        prompting their GP to take actions are eligible.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Referral for bowel examination for other reasons than symptoms. Not able to understand the&#xD;
        instructions for participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louise Olsson, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Örebro län, Camtö</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Lööv, MD</last_name>
    <phone>+46735454965</phone>
    <email>anna.loov@regionorebrolan.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Louise Olsson, MD, PhD</last_name>
    <phone>+46721413970</phone>
    <email>louise.olsson@regionorebrolan.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Skebäcks VC</name>
      <address>
        <city>Örebro</city>
        <zip>702 15</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Lööv, MD</last_name>
      <phone>+46735454965</phone>
      <email>anna.loov@regionorebrolan.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 1, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Örebro County</investigator_affiliation>
    <investigator_full_name>Louise Olsson</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Quantitative faecal immunochemical test, symptomatic, primary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

